Value assessment of antimicrobials using the STEDI framework – How steady is the outcome?

Simon Brassel, Amer Al Taie and Lotte Steuten

Health Policy, 2023, vol. 136, issue C

Abstract: Antimicrobial resistance (AMR) is one of the major threats to global population health, and the antimicrobial market requires substantial reimbursement reform and/or significant financial incentives to function properly.

Keywords: AMR; Broader value of antibiotics; STEDI (search for similar items in EconPapers)
Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S016885102300177X
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:136:y:2023:i:c:s016885102300177x

DOI: 10.1016/j.healthpol.2023.104892

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().